Use este identificador para citar ou linkar para este item:
http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/2021
Registro completo de metadados
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Vitor Kazuo Lotto Takahashi | en_US |
dc.contributor.author | Marcos Balbino | en_US |
dc.contributor.author | Regina Cele Silveira Seixas | en_US |
dc.contributor.author | Aline Domingos Pinto Ruppert | en_US |
dc.contributor.author | Lais Soares de Carvalho | en_US |
dc.date.accessioned | 2024-09-12T15:49:36Z | - |
dc.date.available | 2024-09-12T15:49:36Z | - |
dc.date.issued | 2023 | - |
dc.identifier.citation | Takahashi, Vitor Kazuo Lotto, et al. “Lost to follow-up of patients who received intravitreal anti-vascular endothelial growth factor therapy to treat four different retina disorders in an individual center in Brazil”. SAGE Open Medicine, vol. 11, janeiro de 2023, p. 20503121231199655. DOI.org (Crossref), https://doi.org/10.1177/20503121231199655. | en_US |
dc.identifier.issn | 2050-3121 | - |
dc.identifier.uri | http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/2021 | - |
dc.description.abstract | Objectives: To identify risk factors for loss to follow-up in periodic intravitreal anti-vascular endothelial growth factor injections for the treatment patients with diabetic macular edema, subretinal neovascularization, age-related macular degeneration, and retinal vein occlusion in a single eye center in São Paulo, Brazil. Methods: This was a retrospective longitudinal study that gathered information from 992 patients who required intravitreal anti-vascular endothelial growth factor drugs over 6months. The authors included age, eye disease, laterality, monthly income, distance, and payment mode as risk factors. Results: Two hundred and seventy patients (29.93%) were lost to follow-up. Multivariate analysis showed age, monthly income, eye involvement, and type of medical assistance independently associated with loss to follow-up. The odds of loss to follow-up were greater among older patients than those less than 50years (reference), p<0.001. The odds of loss to follow up were greater among patients who received unilateral treatment than those who received bilateral injections (p=0.013). Concerning gross monthly income, there were no differences in the odds of the four salary strata; the data also indicate an absence of difference in the three strata of patients’ distance to the clinic. Considering the diagnosis, only age-related macular degeneration showed greater odds of loss to follow-up (p=0.016). Finally, the data suggest greater odds of loss to follow-up in private patients than in those on a health care plan (p<0.001). Conclusion: Loss to follow-up is paramount because many patients may remain unassisted concerning their eye diseases. Identifying the risk factors is crucial to enforcing measures to increase adherence and the long-term success of the treatment. | - |
dc.publisher | SAGE Publications | en_US |
dc.relation.ispartof | SAGE open medicine, v. 11, 2023 | en_US |
dc.title | Lost to follow-up of patients who received intravitreal anti-vascular endothelial growth factor therapy to treat four different retina disorders in an individual center in Brazil | en_US |
dc.type | Artigo de Periódico | en_US |
dc.identifier.doi | 10.1177/20503121231199655 | - |
Aparece nas coleções: | Artigos de Periódicos |
Arquivos associados a este item:
Não existem arquivos associados a este item.
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.